TLX Telix Pharmaceuticals Limited
Company Analysis
Latest News
🔴 Telix Pharmaceuticals is trading 6.7% down today in pre-market — no clear catalyst identified
Telix Pharmaceuticals is trading 6.7% down now in pre-market at $11.03 after falling from its August 14 close of $11.82; no clear company-specific catalyst has...
🔴 Telix Pharmaceuticals is trading 6.7% down in pre-market with no clear company-specific catalyst
Telix Pharmaceuticals is trading 6.7% down at $11.03, with no clear company-specific announcement explaining the pre-market decline. - Shares fell from the...
🔴 Telix Pharmaceuticals is trading 4% down today with no clear company-specific catalyst
Telix Pharmaceuticals is trading 4.02% down at $11.83, with no clear company-specific catalyst emerging on August 14, 2026. - The latest investor update...
🔴 Telix Pharmaceuticals is trading 5.3% down in pre-market with no clear company-specific catalyst
Telix Pharmaceuticals is trading at $11.68, down 5.25% in pre-market, with no clear company-specific announcement explaining the decline. - The company last...
Telix Rallies 8% on an Event Invite — Can a Pipeline Showcase Justify a $16-Per-Day Run-Up With No New Data?
Shares surged as Telix Pharmaceuticals announced a September research showcase in New York, capping a 16.6% climb from $9.89 to $11.53 over five trading days —...
🟢 Telix Pharmaceuticals is trading 8% up today after announcing its September 22 R&D Day
Telix Pharmaceuticals is trading 8.41% up at $11.53 after announcing its September 22, 2026 R&D Day in New York. - The event will highlight therapeutic and...
🟢 Telix Pharmaceuticals is trading 8% up today after announcing a September 22 R&D Day
Telix Pharmaceuticals is trading 8.41% up at $11.53 after announcing its September 22, 2026 R&D Day in New York. - The event will cover its therapeutic and...
🟢 Telix Pharmaceuticals is trading 5% up in pre-market after announcing September 22 R&D Day
Telix Pharmaceuticals is trading 5.26% up at $11.20 after announcing on August 6, 2026, that it will host an R&D Day in New York on September 22. - The event...
🔴 Telix Pharmaceuticals is trading 5.1% down
Telix Pharmaceuticals is trading at $10.37, down 5.1% from a comparison close of $10.92 during regular trading. This is a price-action follow-up, so a separate...
🟢 Telix Pharmaceuticals is trading 4.05% up today on strong Q2 revenue growth and pipeline progress
Telix Pharmaceuticals is trading at $10.94 (+4.05%) following a strong Q2 2026 update and positive guidance outlook. • Quarterly revenue reached US$247...
🟢 Telix Pharmaceuticals is trading 4.2% up today on strong Q2 revenue growth and pipeline progress
Telix Pharmaceuticals is trading at $10.95, up 4.2% today, after investors digested a strong quarterly performance and clinical pipeline update. - The company...
Telix Advances Illuccix in Japan, Opens New Melbourne Production Site
Telix Pharmaceuticals completed patient enrollment for its Phase 3 registration study of Illuccix in Japan. The study evaluates the efficacy and safety of...
🔴 Telix Pharmaceuticals is trading 4.8% down today amid profit-taking and consolidation
Telix Pharmaceuticals is trading 4.8% down today at $10.32 amid profit-taking and short-term consolidation following a period of strong gains and heightened...
🔴 Telix Pharmaceuticals is trading 4.3% down today amid broader healthcare sector weakness
Telix Pharmaceuticals is trading 4.3% down today at $11.05 as a broader healthcare sector decline weighs on sentiment, overshadowing the company's latest...
🔴 Telix Pharmaceuticals extends recent weakness amid ongoing regulatory concerns and broader market sentiment
Telix Pharmaceuticals is trading at $10.51 (4.2% down) in after-hours trading, extending recent weakness. • Shares remain under pressure due to the continuing...
🔴 Telix Pharmaceuticals is trading 4.1% down today on capital structure disclosures and high short interest
Telix Pharmaceuticals is trading 4.1% down at $11.23 following multiple ASX filings regarding changes to its securities. • Investors are reacting to a series...
🔴 Telix Pharmaceuticals is trading 5.5% down today following several ASX securities filings
Telix Pharmaceuticals is trading 5.5% down at $11.14 following several ASX filings that have prompted investor repositioning ahead of the U.S. session. • The...
Telix Pharmaceuticals Limited Q1 2026 Earnings Preview: What Analysts Expect on July 02, 2026
Analysts expect Telix Pharmaceuticals to report first-quarter revenue of approximately $230 million and a consensus EPS of -$0.01, while the current stock...
🟢 TLX extends move to 5.1% up
TLX is trading at $11.20, up 5.1% versus the comparison close of $10.66 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 TLX is trading 4.7% up today as pipeline updates and ASCO visibility boost sentiment
TLX is trading 4.7% up today at $11.16 as buyers step in following recent weakness and positive clinical developments. • Telix is highlighting its...